Clinical Trial Update: Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Danshen Gegen (D&G) Capsule for intermittent claudication in peripheral arterial disease; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• Danshen Gegen (D&G) Capsule

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Peripheral Arterial Disease, Intermittent Claudication | Phase 2 | Status: COMPLETED